Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
European Union passes U.S. in COVID-19 vaccination rates
Aug 09, 2021
Rates of people in the 27-member EU with at least one dose have climbed from less than 4% in mid-February to 60%, whereas rates in the United States rose from nearly 12% to less than 58%.
FDA approves second OTC naloxone spray for suspected opioid overdose
Aug 03, 2023
The American Medical Association applauded the approval to improve access to nonprescription naloxone as a way to curb the opioid epidemic.
FDA approves new antibiotic for uncomplicated urinary tract tnfections
Apr 30, 2024
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis,and S. saprophyticus.
FDA approves new two-drug combo medicine for asthma
Jan 12, 2023
The medication is the first approved in the United States to contain an inhaled corticosteroid as a reliever rather than as a controller of asthma symptoms.
No fewer deaths seen with restricted IV fluid for septic shock
Jun 17, 2022
The rates of death at 90 days, serious adverse events, did not differ for patients with septic shock receiving restricted versus standard IV fluid therapy in the ICU.
Most COVID-19-related EUAs not supported by high-quality evidence
Dec 30, 2021
For drugs and vaccines, the emergency use authorizations were mostly supported by randomized clinical trials.
Use of CT angiogram on the rise for headache, dizziness in emergency department
Apr 17, 2024
There was a 67.4% increase in head and neck computed tomography angiography ordering for emergency department patients from 2017 to 2021.
Black seniors with GI malignancy more likely to be frail
Apr 11, 2022
Black patients also were more likely to report limitations in daily living and instrumental activities of daily living.
FDA approves first prescription digital therapy for major depression
Apr 04, 2024
The adjunctive treatment, delivered via smartphone app, reduces depression symptoms in participants on antidepressant medication.